Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
Xiao-Huan TangXiao-Long WuXue-Jun GanYi-Ding WangFang-Zhou JiaYi-Xue WangYan ZhangXiang-Yu GaoZi-Yu LiPublished in: International journal of molecular sciences (2023)
Normalization of CEA/CA19-9 is a strong biomarker for the effectiveness of treatment, and can thus be exploited to prolong the long-term survival of patients with LAGC.